2016 Archives
You are viewing archived information from 2016
SB2713     
Measure Title: RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
Report Title: Patient Protection; Terminal Illness; Investigational Drugs
Description: Grants terminally ill patients access to potentially life-saving investigational drugs, biological products, and devices that are only accessible through clinical trials.
Companion:
Package: None
Current Referral: CPH/EET, JDL
Introducer(s): SLOM, ESPERO, GALUTERIA, GREEN, INOUYE, KEITH-AGARAN, KIDANI, KIM, NISHIHARA, RUDERMAN, SHIMABUKURO, Baker, Gabbard, Ihara, Riviere, L. Thielen, Wakai
Act:

Sort by Date Status Text
1/27/2016SReferred to CPH/EET, JDL.
1/25/2016SPassed First Reading.
1/22/2016SIntroduced.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB2713
All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

Testimony
No testimony available at this time.

Hearing Notices
No hearings scheduled